Thomas Joudinaud

Company: Ceres Brain Therapeutics

Job title: Chief Executive Officer & Co-Founder

Seminars:

Nose to Neuron Delivery of Creatine: Unlocking A Novel Platform for Brain Delivery 11:00 am

Explore evidence of improved memory performance and brain energy modulation Discover innovations in formulation – development of a creatine prodrug capable of passive olfactory nerve entry Designing a phase 2-ready package targeting neurodegenerative diseases and creatine transporter deficiencyRead more

day: Day One - Morning - Track A